Photo of Steve Cohen
D United States House · District 9 · Tennessee

Rep. Steve Cohen

Compare
Total votes
2,837
all sessions
Attendance
97%
97 missed
Lower than 82% of chamber peers
With party
98%
of cast votes
Near the chamber average
Bipartisan score
1%
crosses aisle rarely
Near the chamber average
Sponsored
2,770
bills & resolutions
Higher than 96% of chamber peers
Committees
7
assignments
2,770 bills and resolutions

Sponsored bills

Total
2,770
Primary
198
Co-sponsor
2,572
This page
2,770
matching current filters
Co-sponsor HCONRES 54
In committee · United States House · Co-sponsor
Objecting to the slowdown in mail delivery and postage rate increase instituted by Postmaster General Louis DeJoy and seeking to halt both actions pending further investigation.

This concurrent resolution objects to the slowdown in mail delivery instituted by the Postmaster General and urges that the decisions to slow down mail and increase postage rates be halted immediately pending further investigation and full substantiation by the Postmaster General to Congress.

In committee Oct 12, 2021 1 co-sponsor
Primary HRES 681
In committee · United States House · Lead sponsor
Recognizing the ongoing crackdown on freedom of expression and human rights in Belarus a year after the 2020 election, calling for an end to Alyaksandr Lukashenka's continued campaign of repression against peaceful protesters, journalists, cultural workers, human rights defenders, trade union activists, political activists, and government critics, and expressing solidarity with the Belarusian people.

This resolution condemns Belarusian authorities' assault on freedom of expression and human rights in Belarus since the August 2020 presidential election. The resolution also calls for the immediate release of journalists, cultural figures, and dissidents currently held as political prisoners in Belarus. Furthermore, the resolution calls on the Biden Administration to support initiatives to assist survivors of torture and other human rights violations from Belarus, including by working with allies in the region to grant them protection and providing avenues for them and their families to access safety in the United States; examine all available accountability options for violators of human rights and fundamental freedoms; and demand that Belarus cooperate fully with international partners and organizations, including the United Nations High Commissioner for Human Rights. Finally, the resolution supports the aspirations of the Belarusian people in their struggle for freedom and human rights.

In committee Oct 12, 2021 0 co-sponsors
Co-sponsor HR 5525
In committee · United States House · Co-sponsor
ENABLERS Act

Establishing New Authorities for Businesses Laundering and Enabling Risks to Security Act or the ENABLERS Act This bill expands the definition of a financial institution for purposes of reporting suspicious transactions, anti-money laundering programs, and other related measures. Specifically, the bill expands this definition to include persons who provide investment advice for compensation; persons who trade in works of art, antiques, or collectibles; attorneys, law firms, or notaries involved in financial or related activity on behalf of another person; certain trusts and company service providers; certified public accountants and public accounting firms; persons engaged in the business of public relations, marketing, communications, or other similar services in such a manner as to provide another person anonymity or deniability; and persons engaged in the business of providing third-party payment services. Additionally, the Financial Crimes Enforcement Network must establish a task force to develop a strategy to impose anti-money laundering safeguards and enforce requirements on certain professions. Finally, domestic title insurance companies must obtain, maintain, and report to the Department of the Treasury information on the beneficial owners of entities that purchase or sell residential or commercial real estate in transactions involving the domestic title insurance company.

In committee Oct 8, 2021 1 co-sponsor
Co-sponsor HR 5244
In committee · United States House · Co-sponsor
AFTER Act of 2021

Animal Freedom from Testing, Experiments, and Research Act of 2021 or the AFTER Act of 2021 This bill requires federal research facilities to facilitate the adoption or nonlaboratory placement of certain warm-blooded animals (e.g., dogs, cats, monkeys, guinea pigs, hamsters, and rabbits) with animal rescue organizations, animal sanctuaries, animal shelters, or individuals. In order to be adopted or placed, the animals must (1) no longer be needed for research; (2) be suitable for release; (3) not be birds, rats, or mice.

In committee Oct 5, 2021 1 co-sponsor
Co-sponsor HR 5438
In committee · United States House · Co-sponsor
Water Advanced Technologies for Efficient Resource Use Act of 2021

Water Advanced Technologies for Efficient Resource Use Act of 2021 This bill provides statutory authority for the WaterSense program of the Environmental Protection Agency (EPA) and sets forth related requirements. Under the program, the EPA awards grants to provide incentives for consumers to purchase water-efficient products.

In committee Oct 1, 2021 1 co-sponsor
Co-sponsor HR 4310
In committee · United States House · Co-sponsor
MINKS are Superspreaders Act

Minks in Narrowly Kept Spaces are Superspreaders Act or the MINKS are Superspreaders Act This bill makes it unlawful to import, export, transport, sell, receive, acquire, or purchase American mink ( Neovison vison ) raised in captivity for fur production, whether dead or alive.

In committee Oct 1, 2021 1 co-sponsor
Co-sponsor HR 5473
In committee · United States House · Co-sponsor
Indigenous Peoples’ Day Act

Indigenous Peoples' Day Act This bill designates Indigenous Peoples' Day as a legal public holiday in lieu of Columbus Day.

In committee Sep 30, 2021 1 co-sponsor
Co-sponsor HR 5461
In committee · United States House · Co-sponsor
COVID Defense Act

COVID Defense Act This bill rescinds specified defense appropriations and authorizes funding for manufacturing and delivering COVID-19 vaccines internationally.

In committee Sep 30, 2021 1 co-sponsor
Co-sponsor HR 5426
In committee · United States House · Co-sponsor
Improving Access to Home Dialysis Act of 2021

Improving Access to Home Dialysis Act of 2021 This bill provides for Medicare coverage of staff-assisted home dialysis services for certain individuals with end-stage renal disease (ESRD). Specifically, the bill provides for coverage of services for ESRD individuals who are either initiating peritoneal or home hemodialysis or receiving home dialysis and are unable to self-dialyze due to illness, injury, caregiver issues, or other temporary circumstances. The Centers for Medicare & Medicaid Services must develop a payment system for such services. The bill also requires the development of a patient-centered decision tool that includes home dialysis as an option, as well as a report on racial disparities with respect to the use of staff-assisted home dialysis services.

In committee Sep 30, 2021 1 co-sponsor
Co-sponsor HR 5416
In committee · United States House · Co-sponsor
Give Kids a Chance Act

Give Kids a Chance Act This bill authorizes the Food and Drug Administration (FDA) to take various actions regarding pediatric cancer treatments, such as requiring pediatric cancer trials involving a combination of drugs when an applicant seeks market approval for a new drug (or biological product). For an application for market approval for a new adult cancer treatment drug, if the FDA determines that the drug in question is substantially relevant to the growth or progression of a pediatric cancer, the FDA may require a pediatric cancer investigation into that drug's active ingredient in combination with another active ingredient that has received market approval or an exemption for investigational use. Currently, the FDA may only require a pediatric cancer trial for the drug in the application. Furthermore, when the FDA receives an application for an investigational use exemption for an adult cancer treatment drug, the FDA may require the applicant to conduct up to two preclinical studies to determine the relevance of the drug to pediatric cancer.

In committee Sep 30, 2021 1 co-sponsor
Showing 2,091 to 2,100 of 2,770 bills